SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-148734
Filing Date
2016-11-07
Accepted
2016-11-07 18:56:50
Documents
3
Period of Report
2016-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4254
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 2909
3 EX-24.2 DOCUMENT attachment2.htm EX-24.2 2897
  Complete submission text file 0001209191-16-148734.txt   12544
Mailing Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD
Business Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD 011 44 20 7304 5000
ASTRAZENECA PLC (Reporting) CIK: 0000901832 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33451 | Film No.: 161979566
SIC: 2834 Pharmaceutical Preparations

Mailing Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85
Business Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85 0044 (0) 20 7604 800
ASTRAZENECA AB (Reporting) CIK: 0000928966 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33451 | Film No.: 161979565

Mailing Address 50 MILK STREET 16TH FLOOR BOSTON MA 02109
Business Address 50 MILK STREET 16TH FLOOR BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Issuer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations